Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2004-01-14
2009-08-04
Horlick, Kenneth R. (Department: 1637)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
Reexamination Certificate
active
07569345
ABSTRACT:
The present invention provides gene sets the expression of which is important in the diagnosis and/or prognosis of breast cancer.
REFERENCES:
patent: 4699877 (1987-10-01), Cline et al.
patent: 4968603 (1990-11-01), Slamon et al.
patent: 5015568 (1991-05-01), Tsujimoto et al.
patent: 5202429 (1993-04-01), Tsujimoto et al.
patent: 5459251 (1995-10-01), Tsujimoto et al.
patent: RE35491 (1997-04-01), Cline et al.
patent: 5670325 (1997-09-01), Lapidus et al.
patent: 5741650 (1998-04-01), Lapidus et al.
patent: 5830665 (1998-11-01), Shuber et al.
patent: 5830753 (1998-11-01), Coulie et al.
patent: 5858678 (1999-01-01), Chinnadurai
patent: 5861278 (1999-01-01), Wong et al.
patent: 5928870 (1999-07-01), Lapidus et al.
patent: 5952178 (1999-09-01), Lapidus et al.
patent: 5952179 (1999-09-01), Chinnadurai
patent: 5962312 (1999-10-01), Plowman et al.
patent: 5985553 (1999-11-01), King et al.
patent: 6001583 (1999-12-01), Margolis
patent: 6020137 (2000-02-01), Lapidus et al.
patent: 6100029 (2000-08-01), Lapidus et al.
patent: 6143529 (2000-11-01), Lapidus et al.
patent: 6146828 (2000-11-01), Lapidus et al.
patent: 6171798 (2001-01-01), Levine et al.
patent: 6203993 (2001-03-01), Shuber et al.
patent: 6207401 (2001-03-01), Plowman et al.
patent: 6207452 (2001-03-01), Govindaswamy
patent: 6214558 (2001-04-01), Shuber et al.
patent: 6245523 (2001-06-01), Altieri
patent: 6248535 (2001-06-01), Danenberg et al.
patent: 6271002 (2001-08-01), Linsley et al.
patent: 6322986 (2001-11-01), Ross
patent: 6414134 (2002-07-01), Reed
patent: 6582919 (2003-06-01), Danenberg
patent: 6602670 (2003-08-01), Danenberg
patent: 6618679 (2003-09-01), Loehrlein et al.
patent: 6620606 (2003-09-01), Bandman et al.
patent: 6696558 (2004-02-01), Reed et al.
patent: 6716575 (2004-04-01), Plowman et al.
patent: 6750013 (2004-06-01), Gish et al.
patent: 6800737 (2004-10-01), Altieri
patent: 6943150 (2005-09-01), Altieri
patent: 2001/0051344 (2001-12-01), Shalon et al.
patent: 2002/0004491 (2002-01-01), Xu et al.
patent: 2002/0009736 (2002-01-01), Wang
patent: 2002/0039764 (2002-04-01), Rosen
patent: 2002/0160395 (2002-10-01), Altieri et al.
patent: 2003/0073112 (2003-04-01), Zhang et al.
patent: 2003/0104499 (2003-06-01), Pressman et al.
patent: 2003/0143539 (2003-07-01), Bertucci et al.
patent: 2003/0165952 (2003-09-01), Linnarsson et al.
patent: 2003/0180791 (2003-09-01), Chinnadurai
patent: 2003/0198970 (2003-10-01), Roberts
patent: 2003/0198972 (2003-10-01), Erlander et al.
patent: 2003/0219771 (2003-11-01), Bevilacqua et al.
patent: 2003/0229455 (2003-12-01), Bevilacqua et al.
patent: 2004/0009489 (2004-01-01), Golub et al.
patent: 2004/0126775 (2004-07-01), Altieri et al.
patent: 2004/0133352 (2004-07-01), Bevilacqua et al.
patent: 0 108 564 (1988-05-01), None
patent: 1 365 034 (2003-11-01), None
patent: WO 99/02714 (1999-01-01), None
patent: WO9944062 (1999-09-01), None
patent: WO 00/50595 (2000-08-01), None
patent: WO 00/55173 (2000-09-01), None
patent: WO 00/55180 (2000-09-01), None
patent: WO 02/103320 (2000-12-01), None
patent: WO 01/25250 (2001-04-01), None
patent: WO 01/40466 (2001-06-01), None
patent: WO 01/55320 (2001-08-01), None
patent: WO 01/70979 (2001-09-01), None
patent: WO 01/75160 (2001-10-01), None
patent: WO 02/00677 (2002-01-01), None
patent: WO 02/06526 (2002-01-01), None
patent: WO 02/08260 (2002-01-01), None
patent: WO 02/08261 (2002-01-01), None
patent: WO 02/08282 (2002-01-01), None
patent: WO 02/08765 (2002-01-01), None
patent: WO 02/10436 (2002-02-01), None
patent: WO 02/46467 (2002-06-01), None
patent: WO 02/46467 (2002-06-01), None
patent: WO 02/017852 (2002-07-01), None
patent: WO 02/055988 (2002-07-01), None
patent: WO 02/059271 (2002-08-01), None
patent: WO 02/059377 (2002-08-01), None
patent: WO 02/068579 (2002-09-01), None
patent: WO 03/011897 (2003-02-01), None
patent: WO 03/078662 (2003-09-01), None
patent: WO 03/083096 (2003-10-01), None
Kroese et al (Genetics in Medicine, vol. 6, pp. 475-480, 2004).
Lucentini (The Scientist, vol. 18, p. 20, 2004).
Murphy et al. (Pathology, 2005, vol. 37(4), pp. 271-277).
Korfee et al. (Current Pharmacogenomics, 2005. vol. 3, pp. 201-216).
Search result of MYBL2.
NCBI sequence of NM—002466 and description.
Ahmad, Athar, et al., “Stromelysin 3: An Independent Prognostic Factor for Relapse: Free Survival in Node-Positive Breast Cancer and Demonstration Novel Breast Carcinoma Cell Expression”, American Journal of Clinical Pathology, vol. 152, No. 3, pp. 721-728, Mar. 3, 1998.
Borresen-Dale, A. L. et al, “Genetic Profiling of Breast Cancer: From Molecular Portraits to Clinical Utility”, The International Journal of Biological Markers, vol. 18, No. 1, pp. 54-56, Sep. 20, 2002.
Chenard, Marie-Pierre, et al., “High Levels of Stromelysin-3 Correlate with Poor Prognosis in Patients with Breast Carcinoma”, The Journal of Molecular Diagnostics, vol. 69, No. 6, pp. 448-451, 1996.
Engel, Georg, et al., “Correlation Between Stromelysin-3 mRNA Level and Outcome of Human Breast Cancer”, vol. 58, No. 6, pp. 830-835, 1994.
Forozan, Farahnaz, et al., “Comparative Genomic Hybridization Analysis of 38 Breast Cancer Cell Lines: A Basis for Interpreting Complementary DNA Microarray Data”, Cancer Research, vol. 60, No. 16, pp. 4519-4525, Aug. 15, 2000.
Guérlin, Martine, et al. “Structure and Expression ofcerbB2 and EGF Receptor Genes in Inflammatory and Non-Inflammatory Breast Cancer”, International Journal Cancer, vol. 43, pp. 201-208, 1989.
Leek, Russell, et al., “Association of Macrophage Infiltration with Angiogenesis and Prognosis in Invasive Breast Carcinoma”, Cancer Research, vol. 56, pp. 4625-4629, Oct. 15, 1996.
Murray, P. A., et al., “The Prognostic Significance of Transforming Growth Factors in Human Breast Cancer”, British Journal of Cancer, vol. 67, No. 6, pp. 1408-1412, 1993.
Raschellá, Giuseppe, et al., “Expression ofB-mhyin Neuroblastoma Tumors is a Poor Prognostic Factor Independent from MYCN Amplification”, Cancer Research, vol. 59, pp. 3365-3368, Jul. 15, 1999.
Samuels-Lev, Yardena, et al., “ASPP Proteins Specifically Stimulate the Apoptotic Function of p53”, Molecular Cell, vol. 8, pp. 781-794, Oct. 2001.
Schorr, Kristel, et al. “Bel-2 Gene Family and Related Proteins in Mammary Gland Involution and Breast Cancer”, Journal of Mammary Gland and Neoplasia, vol. 4, No. 2, pp. 153-164, Apr. 1999.
Sens, Mary Ann et al., “Metallothionein Isoform 3 Overexpression is Associated with Breast Cancers having a Poor Prognosis”, American Journal of Pathology, vol. 159, No. 1, Jul. 2001.
Sgroi, Dennis C., et al., “In Vivo Gene Expression Profile Analysis of Human Breast Cancer Progression”, Cancer Research, vol. 59, No. 22, pp. 5656-5661, Nov. 15, 1999.
Ueno, Takayuki et al., “Significance of Macrophage Chemoattractant Protein -1 in Macrophage Recruitment, Angiogenesis and Survival in Human Breast Cancer”. Clinical Cancer Research, vol. 6, pp. 3282-3289, Aug. 2000.
van't Veer, Laura, et al. “Gene Expression Profiling Predicts Clinical Outcome of Breast Cancer”, Nature, vol. 415, No. 6871, Jan. 31, 2002.
Bhattacharjee et al., “Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses”, Proceedings of the National Academy of Sciences of USA, vol. 98, No. 24, pp. 13790-13795, Nov. 20, 2001.
Golub et al., “Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring”, Science, vol. 286, pp. 531-537, Oct. 15, 1999.
Martin et al., “Linking Gene Expression Patterns to Therapeutic Groups in Breast Cancer”, Cancer Research, vol. 60, pp. 2232-2238, Apr. 15, 2000.
Perou et al., “Molecular portraits of human breast tumors”, Nature, vol. 406, pp. 747-752 (2000).
Ramaswamy et al., “Multiclass cancer diagnosis using tumor gene expression signatures”, Proceedings of the National Academy of Sc
Baker Joffre B.
Cobleigh Melody A.
Cronin Maureen T.
Shak Steve
Babic Christopher M.
Bozicevic Field & Francis LLP
Francis Carol L.
Genomic Health, Inc.
Horlick Kenneth R.
LandOfFree
Gene expression markers for breast cancer prognosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gene expression markers for breast cancer prognosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene expression markers for breast cancer prognosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4055683